I started my PhD in 2010 after completing a specialist training in general internal medicine. In 2007 I had 3 months of intensive exposure to cutting edge research at the University of Cambridge, concentrating on the molecular genetics of insulin resistance. The project I helped to develop then, aimed to investigate the relationship between insulin and production of the fat cell hormone adiponectin, which has attracted keen interest as a marker of and potential treatment for diabetes. During my PhD I investigated a rare syndrome of human hypoglycemia and left sided overgrowth, caused by an activating mutation in a critical regulator of the insulin signalling cascade named AKT2. I am currently working towards completion of my PhD thesis, with an aim to go back to practicing clinical endocrine medicine and applying knowledge obtained during my postgraduate training in Cambridge.